Want to see HURN full AI Analyst Report?
Top Page
Huron Consulting
(NASDAQ:HURN)
Select Model
Select Model
Rating:77Outperform
Price Target:
$225.00
▲(43.71% Upside)
Action:Reiterated
Date:10/02/26
The score is driven primarily by strong earnings-call momentum (raised guidance, margin expansion, and robust free cash flow outlook) and constructive technical strength (price above major moving averages with positive MACD). Financial performance is solid but tempered by recent TTM margin compression and some variability in cash conversion/leverage trends. Valuation is a moderate headwind given a 24.59 P/E and no dividend yield provided.
Positive Factors
Sustained Revenue Growth
Strong organic growth and raised full-year guidance indicate durable demand across Huron’s consulting markets. Continued expansion in revenue before reimbursable expenses should support broader client relationships, reinvestment in capabilities, and sustained earnings growth over the next several quarters.
Negative Factors
Recent Margin Compression
The recent decline in gross and EBIT margins indicates that revenue growth has not fully translated into operating leverage. If the lower margin profile persists, it could constrain earnings growth, reduce the benefit of strong demand, and make profitability more sensitive to labor and delivery costs.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained Revenue Growth
Strong organic growth and raised full-year guidance indicate durable demand across Huron’s consulting markets. Continued expansion in revenue before reimbursable expenses should support broader client relationships, reinvestment in capabilities, and sustained earnings growth over the next several quarters.
Read all positive factors
Huron Consulting (HURN) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$3.12B
Dividend YieldN/A
Average Volume (3M)288.04K
Price to Earnings (P/E)28.7
Beta (1Y)0.54
Revenue Growth13.60%
EPS Growth14.77%
CountryUS
Employees9,248
SectorIndustrials
Sector Strength72
IndustryConsulting Services
Share Statistics
EPS (TTM)6.82
Shares Outstanding15,910,072
10 Day Avg. Volume339,539
30 Day Avg. Volume288,042
Financial Highlights & Ratios
PEG Ratio-3.75
Price to Book (P/B)5.71
Price to Sales (P/S)1.78
P/FCF Ratio16.49
Enterprise Value/Market Cap0.74
Enterprise Value/Revenue1.28
Enterprise Value/Gross Profit4.19
Enterprise Value/Ebitda9.87
Forecast
1Y Price Target
$197.67Price Target Upside26.25% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)9.2
Revenue Forecast (FY)$1.87B
Huron Consulting Business Overview & Revenue Model
Company Description
Huron Consulting Group Inc. provides global professional services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The company offers financial and operational performance improve...
How the Company Makes Money
Huron makes money primarily by delivering professional consulting and advisory services to clients and charging for that work, with revenue recognized as services are performed. Its core revenue stream is services revenue generated from client eng...
Huron Consulting Earnings Call Summary
Earnings Call Date:Jul 28, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Nov 03, 2026
Earnings Call Sentiment Positive
The call conveyed strong positive operational and financial momentum: record RBR, robust organic growth, significant adjusted EPS growth (+30% adjusted EPS YoY), margin expansion, strong free cash flow, raised guidance, and accelerating AI-driven digital bookings and managed services. Areas of caution include higher unallocated corporate expenses, a less favorable effective tax rate, leverage that remains above the target range (though improving), and near-term capacity/hiring needs driven by elevated utilization. On balance the positives materially outweigh the challenges.Positive Updates
Record RBR and Revenue Growth
Record revenues before reimbursable expenses (RBR) of $465.6M in Q2 2026, up 15.7% year-over-year (from $402.5M) with 10.8% organic RBR growth in the quarter.
Negative Updates
Rising Unallocated Corporate Expenses
Unallocated corporate expenses (ex-restructuring) rose to $65.4M in Q2 2026 from $54.3M in Q2 2025; excluding deferred compensation impacts, unallocated corporate expenses increased ~$8.7M (including ~$2M of reclassified costs), with expected full-year unallocated corporate expense growth in the low double-digit percent range.
Read all updates
Q2-2026 Updates
Positive
Negative
Record RBR and Revenue Growth
Record revenues before reimbursable expenses (RBR) of $465.6M in Q2 2026, up 15.7% year-over-year (from $402.5M) with 10.8% organic RBR growth in the quarter.
Read all positive updates
Company Guidance
Huron raised and narrowed full-year RBR guidance to $1.85B–$1.89B (≈+12% at the midpoint vs. 2025), maintained adjusted EBITDA margin guidance of 14.5%–15.0% of RBR (≈+50 bps vs. 2025 midpoint) and increased adjusted non‑GAAP EPS to $9.00–$9.40 (≈+17% at the midpoint vs. 2025); free cash flow is expected to be $180M–$220M (net of cash taxes and interest, excl. noncash stock comp) with free cash flow per share at about $12 at the midpoint (≈10% yield at a $120 share price). Management expects RelateCare to add ~$30M of 2026 RBR and be ~+$0.10 accretive to 2026 adjusted EPS, and reiterated segment targets of Healthcare RBR mid‑teen growth with ~30%–32% operating margins, Education RBR mid‑ to upper‑single‑digit growth with 24%–26% margins, and Commercial RBR low‑teen growth with 19%–21% margins; unallocated corporate expenses (ex. restructuring and deferred comp) are expected to rise low‑double‑digits vs. 2025, full‑year diluted shares are guided to ~16.6–16.8M, and the company reiterated its leverage target of 2.0x–2.5x by year‑end (vs. 2.8x adj. EBITDA as of 6/30/26).Huron Consulting Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
72
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.81B | 1.70B | 1.49B | 1.36B | 1.13B | 905.64M |
| Gross Profit | 551.97M | 508.79M | 476.01M | 419.36M | 346.57M | 268.86M |
| EBITDA | 234.22M | 201.71M | 191.89M | 166.19M | 139.08M | 93.00M |
| Net Income | 115.56M | 105.04M | 116.63M | 62.48M | 75.55M | 62.99M |
Balance Sheet | ||||||
| Total Assets | 1.64B | 1.53B | 1.34B | 1.26B | 1.20B | 1.12B |
| Cash, Cash Equivalents and Short-Term Investments | 31.23M | 24.51M | 21.91M | 12.15M | 11.83M | 20.78M |
| Total Debt | 864.54M | 548.34M | 398.61M | 373.88M | 346.09M | 297.24M |
| Total Liabilities | 1.26B | 998.05M | 782.29M | 729.25M | 647.00M | 547.45M |
| Stockholders Equity | 384.76M | 528.63M | 561.33M | 532.89M | 552.04M | 571.90M |
Cash Flow | ||||||
| Free Cash Flow | 161.00M | 182.96M | 192.67M | 100.08M | 61.10M | 2.23M |
| Operating Cash Flow | 178.47M | 193.39M | 201.32M | 135.26M | 85.40M | 17.99M |
| Investing Cash Flow | -123.40M | -145.75M | -79.75M | -36.65M | -20.13M | -20.14M |
| Financing Cash Flow | -84.54M | -45.03M | -111.64M | -98.33M | -74.11M | -44.41M |
Huron Consulting Technical Analysis
Positive
156.57
Price Trends
163.89
Positive
141.46
Positive
138.12
Positive
Market Momentum
9.81
Negative
76.55
Negative
77.72
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HURN, the sentiment is Positive. The current price of 156.57 is below the 20-day moving average (MA) of 174.55, below the 50-day MA of 163.89, and above the 200-day MA of 138.12, indicating a bullish trend. The MACD of 9.81 indicates Negative momentum. The RSI at 76.55 is Negative, neither overbought nor oversold. The STOCH value of 77.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HURN.
Huron Consulting Risk Analysis
Huron Consulting disclosed 34 risk factors in its most recent earnings report. Huron Consulting reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Huron Consulting Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $3.12B | 28.71 | 25.53% | ― | 13.60% | 14.77% | |
74 Outperform | $1.71B | 19.63 | 8.57% | 0.59% | -7.89% | -16.13% | |
72 Outperform | $4.38B | 19.39 | 15.61% | ― | 7.12% | 15.93% | |
70 Outperform | $9.89B | 12.89 | 68.53% | 2.84% | -6.19% | -1.80% | |
65 Neutral | $1.22B | 25.57 | 24.76% | 1.17% | 11.46% | -9.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
45 Neutral | $91.26M | -1.93 | -25.92% | 10.65% | -19.60% | 76.21% |
* Industrials Sector Average
HURN
Huron Consulting
195.80
43.32
28.41%
BAH
Booz Allen
83.40
0.30
0.36%
CRAI
Cra International
194.30
13.94
7.73%
FCN
FTI Consulting
158.80
-11.27
-6.63%
ICFI
Icf International
95.39
7.90
9.03%
RGP
Resources Connection
2.63
-1.58
-37.49%
Huron Consulting Corporate Events
Business Operations and StrategyExecutive/Board Changes
Huron Consulting Adds Dr. Richards to Board of Directors
Positive
Jul 27, 2026
On July 23, 2026, Huron Consulting Group Inc. appointed Dr. L. Thomas Richards to its Board of Directors to serve until the 2027 Annual Meeting of Stockholders, assigning him to the Nominating and Corporate Governance, Finance and Capital Allocati...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.